Sage Therapeutics Announces Phase 2 Results for Dalzanemdor
20 Nov 2024 //
BUSINESSWIRE
Sage Therapeutics scraps Alzheimer’s drug after trial fails
09 Oct 2024 //
REUTERS
Sage`s dalzanemdor trial design leaves efficacy question unclear
11 Jun 2024 //
FIERCE BIOTECH
Sage Axes Parkinson’s Program for Dalzanemdor After Phase II Flop
18 Apr 2024 //
REUTERS